Parabilis Medicines, Inc. — Form 8-K
Filed September 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Parabilis Medicines filed an 8-K on 2026-09-15 containing only Item 7.01 (Regulation FD Disclosure). The specific disclosure content is not provided in the filing metadata supplied. No material transaction, agreement, leadership change, financing, or operational event is described in the available text.
Why this rating
Routine regulatory filing with no substantive disclosure details provided; typical administrative disclosure absent material business impact.
Extracted items
See more from September 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.